Detailansicht

Wissensnetz

Person

Stefan Wiemann

Biologe

Name	Stefan Wiemann
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. rer. nat.
Beruf	Biologe (charakteristischer Beruf)
Beziehung	Universität Heidelberg. Fakultät für Biowissenschaften
Weitere Angaben	Deutsches Krebsforschungszentrum und NCT, Heidelberg, Germany
Datensatztyp	Person
GND-Nummer	1105581209
Datensatz-ID	1105581209
Beteiligt an alle anzeigen GRB2 is a BECN1 interacting protein that regulates autophagy HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets Characterisation of tumour-intrinsic determinants and drug-induced modulation of response to CD19-CAR T-cells in nodal B-cell non-Hodgkin lymphomas Clonal heterogeneity of endocrine therapy resistance in breast cancer Finding new combinatory treatment avenues for glioblastoma patients High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome 5’isomiR-183-5p/+2 elicits tumor suppressor activity in a negative feedback loop with E2F1 Disentangling ERBB signaling in breast cancer subtypes - a model-based analysis The genomic and transcriptional landscape of primary central nervous system lymphoma TNFα-activated fibroblasts support tumor progression in Luminal A breast cancer Characterization of the transcription factor MEOX2 as a potential oncogene in gliomas The impact of stromal fibroblasts on therapy response in breast cancer Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER Identification of transcription factors that specifically bind methylated recognition sites Identifying and characterizing functionally relevant microRNAs and 5’isomiRs in triple-negative breast cancer ROLE OF STC1 IN THE ACTIVATION OF FIBROBLASTS IN THE CONTEXT OF BREAST CANCER Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands Dissecting the miRNome impact on metastatic pathways in Triple Negative Breast Cancer Investigating the role of alanine aminotransferase 2 in breast cancer Identification of SLC20A1 and SLC15A4 among other genes as potential risk factors for combined pituitary hormone deficiency Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors ERBB2 as a driver of an invasive phenotype of cells grown in 3D culture and an important regulator of oncogenic miRNAs' expression in breast cancer Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers The Proteomic Landscape of Breast Cancer Metabolism Chemokine axes in breast cancer : factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors Homozygous missense mutation in the LMAN2L gene segregates with intellectual disability in a large consanguineous Pakistani family So rare we need to hunt for them: reframing the ethical debate on incidental findings The transcription factor SOX11 is a potential tumor suppressor in myxoid liposarcomas: Analysis of function, target genes and mutation Protein signatures of oxidative stress response in a patient specific cell line model for autism Protein signatures of oxidative stress response in a patient specific cell line model for autism Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the in cis downregulation of a gene cluster that targets NF-kB

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Stefan Wiemann

GRB2 is a BECN1 interacting protein that regulates autophagy

HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer

Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets

Characterisation of tumour-intrinsic determinants and drug-induced modulation of response to CD19-CAR T-cells in nodal B-cell non-Hodgkin lymphomas

Clonal heterogeneity of endocrine therapy resistance in breast cancer

Finding new combinatory treatment avenues for glioblastoma patients

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome

5’isomiR-183-5p/+2 elicits tumor suppressor activity in a negative feedback loop with E2F1

Disentangling ERBB signaling in breast cancer subtypes - a model-based analysis

The genomic and transcriptional landscape of primary central nervous system lymphoma

TNFα-activated fibroblasts support tumor progression in Luminal A breast cancer

Characterization of the transcription factor MEOX2 as a potential oncogene in gliomas

The impact of stromal fibroblasts on therapy response in breast cancer

Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER

Identification of transcription factors that specifically bind methylated recognition sites

Identifying and characterizing functionally relevant microRNAs and 5’isomiRs in triple-negative breast cancer

ROLE OF STC1 IN THE ACTIVATION OF FIBROBLASTS IN THE CONTEXT OF BREAST CANCER

Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer

Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands

Dissecting the miRNome impact on metastatic pathways in Triple Negative Breast Cancer

Investigating the role of alanine aminotransferase 2 in breast cancer

Identification of SLC20A1 and SLC15A4 among other genes as potential risk factors for combined pituitary hormone deficiency

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors

ERBB2 as a driver of an invasive phenotype of cells grown in 3D culture and an important regulator of oncogenic miRNAs' expression in breast cancer

Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers

The Proteomic Landscape of Breast Cancer Metabolism

Chemokine axes in breast cancer : factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors

Homozygous missense mutation in the LMAN2L gene segregates with intellectual disability in a large consanguineous Pakistani family

So rare we need to hunt for them: reframing the ethical debate on incidental findings

The transcription factor SOX11 is a potential tumor suppressor in myxoid liposarcomas: Analysis of function, target genes and mutation

Protein signatures of oxidative stress response in a patient specific cell line model for autism

Protein signatures of oxidative stress response in a patient specific cell line model for autism

Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the in cis downregulation of a gene cluster that targets NF-kB